Clearance Summary
ClearLLab T1, ClearLLab T2, ClearLLab B1, ClearLLab B2, ClearLLab M received FDA 510(k) clearance under submission number DEN160047, sponsored by Beckman Coulter. The device was reviewed via the Direct premarket notification pathway and assigned to the Hematology review panel. The statutory decision date of record is 2017-06-29.
- Submission: DEN160047
- Applicant / Sponsor: Beckman Coulter
- Clearance pathway: Direct
- Review panel: Hematology
- Device class: Class II
- Regulation citation: 21 CFR 864.7010
- Decision date: 2017-06-29
Classification & Regulation
This clearance is catalogued under FDA product code PWD and 21 CFR 864.7010, within the Hematology review panel as a Class II device.